NCT06076798View on ClinicalTrials.gov

Clinical Performance of AFGen1

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

November 5, 2023

Study Completion Date

November 24, 2023

Conditions
Atrial FibrillationAfibECG
Interventions
DEVICE

ECG co-measurement

Measure ECG with 12 lead device at same time that AFGen1 is monitoring ECG

Trial Locations (1)

92110

4927 Lillian Street, San Diego

All Listed Sponsors
lead

TriVirum, Inc.

INDUSTRY

NCT06076798 - Clinical Performance of AFGen1 | Biotech Hunter | Biotech Hunter